Pune: A significant rise in pneumonia cases affecting children, particularly those with severe complications like pleural ...
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal hemoglobinuria and primary immunoglobulin A nephropathy.
5d
Sinar Daily on MSNBeyond The Flu: The Silent Threat Of Pneumococcal PneumoniaLast year alone, pneumonia accounted for 18,181 deaths in Malaysia, making up 15.2 per cent of all medically certified ...
Objective: To compare the safety and efficacy of clarithromycin and amoxicillin/clavulanic acid in patients with community-acquired pneumonia due to penicillin ...
Phase III study showed sustained proteinuria reduction at one year with favorable safety1 <li /> Fabhalta is the only or ...
14don MSN
Pneumonia infects millions of people every year. Cases of this highly contagious lung infection surged across all age groups in 2024, but young children were hit particularly hard. Infection rates in ...
19h
MedPage Today on MSNFirst Drug Approved for Ultra-Rare Kidney DiseaseThe FDA approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3 glomerulopathy ...
Here's what causes bronchitis, how the illness usually spreads and how you can treat symptoms if it affects you or a loved ...
Double pneumonia can be caused by bacteria, viruses, or fungi and is caused most often by Streptococcus pneumoniae, influenza viruses, and respiratory syncytial virus (RSV). Those with compromised ...
“One notorious polymicrobial combination is influenza followed by a bacterial infection like Streptococcus pneumoniae — the most common bacterial cause of pneumonia — or Staph aureus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results